WMA Declaration of Helsinki – Ethical Principles f... ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Drug candidate slows motor neuron disease progress...
A Professional Overview of Hypertension ...
Long-term physical activity protects against metabolic syndr...
January 17,2026
Controlling hypertension can reduce dementia risk—even when ...
January 16,2026
Assessing methods for improving access to trauma care for ki...
January 15,2026
Portable device could help scientists track Alzheimer's dise...
January 14,2026
Neurons use physical signals, not electricity, to stabilize ...
January 13,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Dr. Fauci among hundreds who've contract...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
Announcement of the 2025 Nobel Prize in ...
More News
Not all patients want faster cancer drug approvals without certainty they work

Not all patients want faster cancer drug approvals without certainty they work

byLondon School of EconomicsCredit: Pixabay/CC0 Public DomainPatients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are approved by th
Oncology November 29,2024
Not all patients want faster cancer drug approvals without certainty they work

Not all patients want faster cancer drug approvals without certainty they work

byLondon School of EconomicsCredit: Pixabay/CC0 Public DomainPatients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are approved by th
Oncology November 29,2024
Repurposed FDA-approved drug could uncover potential treatment for rare genetic disorders

Repurposed FDA-approved drug could uncover potential treatment for rare genetic disorders

byMcMaster UniversityMass neuronal loss throughout the spinal cord of SD mice at terminal disease stage. Credit:Human Molecular Genetics(2024). DOI: 10.1093/hmg/ddae153In a new study
Neurology November 29,2024
Repurposed FDA-approved drug could uncover potential treatment for rare genetic disorders

Repurposed FDA-approved drug could uncover potential treatment for rare genetic disorders

byMcMaster UniversityMass neuronal loss throughout the spinal cord of SD mice at terminal disease stage. Credit:Human Molecular Genetics(2024). DOI: 10.1093/hmg/ddae153In a new study
Neurology November 29,2024
Doctors may soon use an AI-driven solution to personalize antibiotic prescriptions

Doctors may soon use an AI-driven solution to personalize antibiotic prescriptions

Doctors may soon use an AI-driven solution to personalize antibiotic prescriptionsbySingHealthCredit: Unsplash/CC0 Public DomainDoctors may soon use an AI-driven solution to swiftly prescribe a
Technology & AI November 29,2024
Doctors may soon use an AI-driven solution to personalize antibiotic prescriptions

Doctors may soon use an AI-driven solution to personalize antibiotic prescriptions

Doctors may soon use an AI-driven solution to personalize antibiotic prescriptionsbySingHealthCredit: Unsplash/CC0 Public DomainDoctors may soon use an AI-driven solution to swiftly prescribe a
Technology & AI November 29,2024
FDA approves Cobenfy for adults with schizophrenia

FDA approves Cobenfy for adults with schizophrenia

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schiz
Psychiatry & Mental Health November 29,2024
FDA approves Cobenfy for adults with schizophrenia

FDA approves Cobenfy for adults with schizophrenia

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schiz
Psychiatry & Mental Health November 29,2024
Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science
Public Health & Prevention November 29,2024
Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science
Public Health & Prevention November 29,2024
Researchers uncover how blood pressure drugs harm kidneys

Researchers uncover how blood pressure drugs harm kidneys

by Mike Mather,University of VirginiaCredit: Unsplash/CC0 Public DomainCommonly prescribed drugs used to treat high blood pressure have been shown to, over time, wreck the kidneys' ability t
Nephrology & Urology November 29,2024
Researchers uncover how blood pressure drugs harm kidneys

Researchers uncover how blood pressure drugs harm kidneys

by Mike Mather,University of VirginiaCredit: Unsplash/CC0 Public DomainCommonly prescribed drugs used to treat high blood pressure have been shown to, over time, wreck the kidneys' ability t
Nephrology & Urology November 29,2024
Risk of internal bleeding doubles when people on anticoagulants take NSAID painkiller, study finds

Risk of internal bleeding doubles when people on anticoagulants take NSAID painkiller, study finds

byEuropean Society of CardiologyInteractions between non-steroidal anti-inflammatory drugs (NSAIDs) and oral anticoagulants (OACs) that may contribute to excess risk of gastrointestinal (GI) and
Cardiovascular Diseases November 29,2024
Risk of internal bleeding doubles when people on anticoagulants take NSAID painkiller, study finds

Risk of internal bleeding doubles when people on anticoagulants take NSAID painkiller, study finds

byEuropean Society of CardiologyInteractions between non-steroidal anti-inflammatory drugs (NSAIDs) and oral anticoagulants (OACs) that may contribute to excess risk of gastrointestinal (GI) and
Cardiovascular Diseases November 29,2024
Neuropathic pain drugs linked to higher hip fracture risk in seniors

Neuropathic pain drugs linked to higher hip fracture risk in seniors

by Teju Hari Krishna,Monash UniversityCredit: Pixabay/CC0 Public DomainA new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat neu
Orthopedics & Sports medicine November 29,2024
Neuropathic pain drugs linked to higher hip fracture risk in seniors

Neuropathic pain drugs linked to higher hip fracture risk in seniors

by Teju Hari Krishna,Monash UniversityCredit: Pixabay/CC0 Public DomainA new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat neu
Orthopedics & Sports medicine November 29,2024
More than half of U.S. adults could be candidates for Ozempic

More than half of U.S. adults could be candidates for Ozempic

by Ernie MundellMore than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds.Sold as Ozempic for treating&nbsp
Diabetes & Endocrinology November 29,2024
More than half of U.S. adults could be candidates for Ozempic

More than half of U.S. adults could be candidates for Ozempic

by Ernie MundellMore than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds.Sold as Ozempic for treating&nbsp
Diabetes & Endocrinology November 29,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... Health spending has been rising across rich countries with different systems ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com